Inactive Instrument

Peregrine Pharmaceuticals Stock Nasdaq

Equities

US7136615025

Pharmaceuticals

Sales 2024 * 139M Sales 2025 * 166M Capitalization 434M
Net income 2024 * -16M Net income 2025 * -4M EV / Sales 2024 * 3.13 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.62 x
P/E ratio 2024 *
-26.6 x
P/E ratio 2025 *
-109 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.9%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Peregrine Pharmaceuticals

Managers TitleAgeSince
Chief Executive Officer 60 20-07-29
Director of Finance/CFO 50 18-07-31
Chief Tech/Sci/R&D Officer - 98-12-31
Members of the board TitleAgeSince
Director/Board Member 59 17-11-26
Chairman 78 17-11-26
Director/Board Member 68 19-07-24
More insiders
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.
Calendar
Related indices
More about the company